Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3670956 | 0.90 | LMNA (0.39) | LMNA | |
| SCHEMBL2652 | 0.80 | — | — | |
| SCHEMBL8919696 | 0.76 | — | — | |
| SCHEMBL3367366 | 0.73 | ALDH1A1 (0.33) | — | |
| SCHEMBL30973710 | 0.73 | LMNA (0.39) | LMNA | |
| SCHEMBL9299455 | 0.73 | — | — | |
| SCHEMBL4396257 | 0.70 | LMNA (0.48) | LMNA | |
| SCHEMBL1174723 | 0.69 | — | — | |
| SCHEMBL5694826 | 0.68 | — | — | |
| SCHEMBL1246847 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9487494-B2 | Cyclic hydrocarbon compounds for the treatment of diseases | LEO PHARMA A/S (DK) | 2016-11-08 | — | — | US | claimed |
| US-20100317582-A1 | NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES | LEO PHARMA A/S (DK) | 2010-12-16 | — | — | US | claimed |
| EP-2234961-A2 | NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES | LEO PHARMA A/S (DK) | 2010-10-06 | — | — | EP | claimed |
| WO-2009065406-A2 | NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES | LEO PHARMA A/S (DK) | 2009-05-28 | — | — | WO | claimed |
| US-20240182631-A1 | RANDOM COPOLYMER AND METHOD OF PRODUCING SAME | ZEON CORPORATION (JP) | 2024-06-06 | — | — | US | disclosed |
| EP-4317241-A1 | RANDOM COPOLYMER AND METHOD FOR MANUFACTURING SAME | Zeon Corporation (JP) | 2024-02-07 | — | — | EP | disclosed |
| CN-116964124-A | Random copolymer and method for producing same | 日本瑞翁株式会社 | 2023-10-27 | — | — | CN | disclosed |
| WO-2022210407-A1 | RANDOM COPOLYMER AND METHOD FOR MANUFACTURING SAME | 日本ゼオン株式会社 | 2022-10-06 | — | — | WO | disclosed |
| EP-0702266-B1 | Dry type image formation process | FUJI PHOTO FILM CO LTD (JP) | 2002-03-20 | — | — | EP | disclosed |
| US-5670292-A | IMAGEWISE EXPOSING HEAT DEVELOPABLE PHOTOSENSITIVE MATERIAL TO LIGHT; RUPTURING MICROCAPSULES CONTAINING SILVER HALIDE FIXING AGENT | FUJI PHOTO FILM CO., LTD. (JP) | 1997-09-23 | — | — | US | disclosed |
| EP-0431568-B1 | Method for processing a silver halide photographic material | FUJI PHOTO FILM CO LTD (JP) | 1996-10-16 | — | — | EP | disclosed |
| EP-0702266-A1 | Dry type image formation process | FUJI PHOTO FILM CO., LTD. (JP) | 1996-03-20 | — | — | EP | disclosed |
| US-5415983-A | Method for processing a silver halide photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1995-05-16 | — | — | US | disclosed |
| US-5401621-A | Improved desilvering, nonstainig, stability | FUJI PHOTO FILM CO., LTD. (JP) | 1995-03-28 | — | — | US | disclosed |
| US-5192647-A | Forming latent images | FUJI PHOTO FILM CO., LTD. (JP) | 1993-03-09 | — | — | US | disclosed |
| EP-0283041-B1 | DIRECT POSITIVE SILVER HALIDE PHOTOSENSITIVE MATERIAL AND METHOD FOR FORMING DIRECT POSITIVE IMAGE | FUJI PHOTO FILM CO., LTD. (JP) | 1992-10-07 | — | — | EP | disclosed |
| EP-0496887-A1 | PROCESS FOR TREATING SILVER HALIDE PHOTOGRAPHIC METERIAL AND COMPOSITION THEREFOR | FUJI PHOTO FILM CO., LTD. (JP) | 1992-08-05 | — | — | EP | disclosed |
| EP-0431568-A1 | Method for processing a silver halide photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1991-06-12 | — | — | EP | disclosed |
| US-4952483-A | NOVEL HYDRAZINE NUCLEATING AGENTS AND ACCELERATORS | FUJI PHOTO FILM CO., LTD. (JP) | 1990-08-28 | — | — | US | disclosed |
| US-4871653-A | DEVELOPING IN PRESENCE OF MERCAPTO POLYAZAINDENE PROMOTERS AND NUCLEATING QUATERNARY OR HYDRAZIDE-TYPE COMPOUNDS | FUJI PHOTO FILM CO., LTD. (JP) | 1989-10-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317582-A1 | NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES | ARNT, AHR, CYP27A1 | LMNA 1156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.